Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,500 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07837427Recruiting
Different water pressures during minimally invasive back surgery
This study compares two different water pressures used during a minimally invasive back surgery to see if one causes fewer complications and gives the surgeon a clearer view. It aims to help improve recovery and surgical outcomes for people with lower back problems.
Kunming, YunnanAges 18–75 - NCT07834346RecruitingPhase 3
Clarithromycin to prevent new infections in sepsis after pneumonia
This study tests whether an antibiotic called clarithromycin can help prevent additional infections in people who have sepsis from pneumonia. The goal is to see if it helps you recover faster and avoid complications.
Pátrai, AchaeaAges 18 years+ - NCT07835256Recruiting
Virtual reality training for rheumatology staff
This trial tests a training program that combines online learning with virtual reality to help healthcare providers in rheumatology improve their skills. It may benefit patients by ensuring their care team is well-trained in managing rheumatic conditions.
Leiden, South HollandAges 18 years+ - NCT07835308RecruitingEarly Phase 1
Smart tuning of brain stimulation for better walking
This study is testing a new way to adjust deep brain stimulation (DBS) settings to improve walking in people with Parkinson's disease. If you have DBS and can walk with stimulation off, this trial may help fine-tune your treatment to improve your gait.
Minneapolis, MinnesotaAges 18 years+ - NCT07835945Recruiting
Testing blood gas from artery vs fingertip in breathing distress
This trial compares blood drawn from an artery (arterial blood gas) with blood from a fingertip (capillary blood gas) to see if the fingertip test gives accurate enough results for patients in the emergency room with breathing problems caused by COPD or heart failure. It might help reduce the pain and discomfort of repeated artery tests.
NiceAges 18 years+ - NCT07834840Enrolling by invitation
Diet education for gout patients on urate-lowering therapy
This trial tests whether extra diet advice helps people with gout who are already taking urate-lowering medicine. It might help them manage their condition better.
Suwon, Gyeonggi-doAges 19 years+ - NCT07837375Recruiting
Physical activity support app for COPD patients
This study tests a mobile app that helps people with COPD exercise more safely, possibly by giving them better tips and reminders. It aims to see if the app can improve their daily activity and overall wellbeing.
MontivilliersAges 18 years+ - NCT07839975Recruiting
Wrist device study for college students' fitness
This study uses a wrist-worn device to measure college students' physical fitness and connects it to traditional Chinese medicine body type. It may help show how your personal health profile relates to your exercise ability.
Guangzhou, GuangdongAges 18–25 - NCT07836361Recruiting
A study following people with systemic sclerosis over time
This study follows people with systemic sclerosis (a condition that causes hardening and tightening of the skin and can affect organs) to learn more about the disease over time. By joining, you help researchers understand it better, and you may get more careful monitoring.
BeijingAges Up to 100 years - NCT07839741RecruitingPhase 4
Lowering cholesterol with ezetimibe
This trial looks at how well ezetimibe, a medicine that lowers cholesterol, works when taken alone or alongside other cholesterol medicines. It may help people who need extra help lowering their LDL (bad) cholesterol.
PortoAges 18–75 - NCT06462768Recruiting
Study of immune cell activity in systemic sclerosis
This study looks at a specific type of immune cell activity (called neutrophil extracellular traps) in the blood of people with systemic sclerosis, other connective tissue diseases, and healthy volunteers. It aims to understand how these cells may be involved in the disease and could lead to better treatments.
ReimsAges 18 years+ - NCT06464068RecruitingPhase 2
Immunotherapy plus chemo for first-line advanced extrapulmonary small cell cancer
This trial tests a new combination of durvalumab (an immunotherapy) plus standard chemotherapy for people with advanced small cell carcinoma that started outside the lung and has not been treated before. The goal is to see if this combo works better than chemo alone.
Reggio EmiliaAges 18 years+ - NCT06463834RecruitingPhase 2
Sintilimab plus chemo before surgery for esophageal cancer
This study tests a combination of an immunotherapy drug (sintilimab) with chemotherapy given before surgery for a type of esophageal cancer called squamous cell carcinoma. The goal is to see if this treatment shrinks the tumor and improves outcomes.
Fuzhou, FujianAges 18–75 - NCT04847752Recruiting
Predicting outcomes after stroke from artery plaque
This study looks at factors that can help predict recovery and risk after an ischemic stroke caused by plaque buildup in a major artery. It may help doctors better forecast prognosis and tailor follow-up care for people like you.
WuhanAges Up to 80 years - NCT06466018Recruiting
Eye disorder biomarkers study for European adults
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
ParisAges 18 years+ - NCT06467786RecruitingPhase 4
Irinotecan liposomes for advanced small cell lung cancer
This trial is testing a new form of chemotherapy called irinotecan liposomes for people with advanced small cell lung cancer that has worsened after initial treatment. It aims to see if this drug can shrink tumors and improve survival.
Xi'an, ShannxiAges 18 years+ - NCT06467500RecruitingPhase 2
Cadonilimab plus chemo for lung cancer after immunotherapy
This trial tests a new drug called cadonilimab combined with chemotherapy for people with advanced lung cancer who have already tried and failed immunotherapy. It aims to see if this combination can help when standard immunotherapy no longer works.
YichangAges 18–75 - NCT07827014Recruiting
Protein shake study for healthy adults
This study tests a daily protein shake in two flavors to see how well people tolerate it and if it affects their well-being. You would drink it once a day for 15 days and answer some questionnaires.
Carlsbad, CaliforniaAges 21–65 - NCT07826689RecruitingPhase 1/Phase 2
Oral pill for relapsing multiple sclerosis
This study tests an experimental oral drug, PRO-1562, in two parts: first in healthy volunteers to check safety, then in people with relapsing multiple sclerosis to see if it can reduce disease activity. It may offer a new, convenient treatment option.
Adelaide, South AustraliaAges 18–65 - NCT07827586Recruiting
Ocrelizumab injection for relapsing-remitting multiple sclerosis
This study looks at how well the injected form of ocrelizumab works for people with relapsing-remitting multiple sclerosis (RRMS) in everyday care. It aims to understand the treatment's effects and side effects outside of a clinical trial setting.
LjubljanaAges 18 years+ - NCT07830550Enrolling by invitation
Blood donation study for a syphilis test
This study is collecting blood samples from healthy adults to help develop a new test for syphilis, an infection that can be spread through sex. If you are willing to give a small blood sample, you may be able to join and help improve testing.
Salem, New HampshireAges 22 years+ - NCT07830342RecruitingPhase 1
Study of tumor-infiltrating lymphocyte therapy for advanced non-small cell lung cancer
This trial tests a new cell therapy that uses your own immune cells (TILs) to fight lung cancer. If you have advanced non-small cell lung cancer and standard treatments haven't worked, this treatment might help your immune system attack the cancer more effectively.
ShanghaiAges 18–75 - NCT07832552Enrolling by invitationPhase 3
Eye drop treatment for pain and swelling after cataract surgery
This study tests a medication given as an injection during cataract surgery to prevent eye pain and swelling. It aims to see if it helps you recover more comfortably.
Kansas City, MissouriAges 18 years+ - NCT07831213Recruiting
Safety and performance study of a lip filler
This study is testing a new lip filler to see if it works well and is safe. It may help people who want to improve the look of their lips.
Lod, IsraelAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,500 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.